Regulation of Lipoprotein Transport in Metabolic Syndrome

NCT00841217 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Lipid Disorders
Cardiovascular Disease

Interventions

DRUG: GW501516
DRUG: placebo pill

Sponsor

The University of Western Australia

Collaborators

[object Object]